Abstract |
We evaluated if ONO-1714, known as an inducible nitric oxide synthase (iNOS) inhibitor, could inhibit neuronal NOS (nNOS) and exert antinociception. ONO-1714 potently inhibited both crude rat cerebellar NOS and recombinant human nNOS in vitro. Systemic ONO-1714 at 1-10 mg/kg suppressed carrageenan-induced thermal hyperalgesia in rats, an effect being equivalent to the antinociception caused by L-NAME or 7-nitroindazole at 25 mg/kg. The same doses of ONO-1714 also caused hypertension. Intrathecal (i.t.) ONO-1714 potently reduced the hyperalgesia, the effective dose range (0.2-0.6 microg/rat) being much lower than the antinociceptive dose (150 microg/rat) of i.t. L-NAME. Thus, ONO-1714 is considered a potent inhibitor of nNOS in addition to iNOS. The distinct relative antinociceptive activities of systemic and i.t. ONO-1714 are attributable to its possible poor blood-brain barrier permeability.
|
Authors | Fumiko Sekiguchi, Yoko Mita, Yoshihisa Kamanaka, Naoyuki Kawao, Hidekazu Matsuya, Chiyomi Taga, Atsufumi Kawabata |
Journal | Neuroscience letters
(Neurosci Lett)
Vol. 365
Issue 2
Pg. 111-5
(Jul 22 2004)
ISSN: 0304-3940 [Print] Ireland |
PMID | 15245789
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- 7-chloro-3-imino-5-methyl-2-azabicyclo(4.1.0)heptane
- Amidines
- Analgesics
- Heterocyclic Compounds, 2-Ring
- Indazoles
- Recombinant Proteins
- Carrageenan
- NOS1 protein, human
- NOS2 protein, human
- Nitric Oxide Synthase
- Nitric Oxide Synthase Type I
- Nitric Oxide Synthase Type II
- Nos1 protein, rat
- Nos2 protein, rat
- 7-nitroindazole
- NG-Nitroarginine Methyl Ester
|
Topics |
- Amidines
(administration & dosage, pharmacology)
- Analgesics
(pharmacology)
- Animals
- Carrageenan
- Cerebellum
(enzymology)
- Heating
- Heterocyclic Compounds, 2-Ring
(administration & dosage, pharmacology)
- Humans
- Hyperalgesia
(chemically induced, drug therapy, enzymology)
- Indazoles
(pharmacology)
- Injections, Intraperitoneal
- Injections, Spinal
- Male
- NG-Nitroarginine Methyl Ester
(pharmacology)
- Nitric Oxide Synthase
(antagonists & inhibitors)
- Nitric Oxide Synthase Type I
- Nitric Oxide Synthase Type II
- Rats
- Rats, Wistar
- Recombinant Proteins
(antagonists & inhibitors)
|